32163 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 23
00:42 UTC
|
TOL
Toll Brothers
|
◎ Target | Anthony Pettinari ★★★★☆ #609 | Buy | $176.00→ $179.00+1.7% |
|
Aug 23
00:42 UTC
|
TLN
Talen Energy
|
◎ Target | David Arcaro ★★★☆☆ #2079 | Overweight | $508.00→ $503.00-1.0% |
|
Aug 23
00:42 UTC
|
TD
Toronto-Dominion Bank
|
◎ Target | firm only | C$140.00→ C$164.00+17.1% | |
|
Aug 23
00:42 UTC
|
STUB
STUB
|
◎ Target | John Blackledge ★★★★☆ #506 | Buy | $16.00→ $12.00-25.0% |
|
Aug 23
00:42 UTC
|
SRE
Sempra Energy
|
◎ Target | David Arcaro ★★★☆☆ #2079 | Overweight | $108.00→ $104.00-3.7% |
|
Aug 23
00:42 UTC
|
SR
Spire
|
◎ Target | Stephen Byrd ★☆☆☆☆ #3175 | Overweight | $96.00→ $91.00-5.2% |
|
Aug 23
00:42 UTC
|
SO
Southern
|
◎ Target | Stephen Byrd ★☆☆☆☆ #3175 | Underweight | $92.00→ $89.00-3.3% |
|
Aug 23
00:42 UTC
|
SNDX
Syndax Pharmaceuticals
|
◎ Target | David Dai ★★★★☆ #414 | Buy | $37.00→ $33.00-10.8% |
|
Aug 23
00:42 UTC
|
SLDB
Solid Biosciences
|
◎ Target | Danielle Brill ★★★☆☆ #2142 | Buy | $16.00→ $20.00+25.0% |
|
Aug 23
00:42 UTC
|
SHI
SIG
|
◎ Target | firm only | Hold | GBX 8.90→ GBX 9.60+7.9% |
|
Aug 23
00:42 UTC
|
SBGI
Sinclair
|
◎ Target | David Karnovsky ★★★★☆ #927 | Underweight | $14.00→ $15.00+7.1% |
|
Aug 23
00:42 UTC
|
S
SentinelOne
|
◎ Target | Brian Essex ★★☆☆☆ #2274 | Neutral | $18.00→ $22.00+22.2% |
|
Aug 23
00:42 UTC
|
RY
Royal Bank of Canada
|
◎ Target | firm only | C$260.00→ C$300.00+15.4% | |
|
Aug 23
00:42 UTC
|
RWT
Redwood Trust
|
◎ Target | Marissa Lobo not yet tracked | Buy | $7.00→ $6.50-7.1% |
|
Aug 23
00:42 UTC
|
RVMD
Revolution Medicines
|
◎ Target | Jeffrey Walch not yet tracked | Market Perform | $151.00→ $179.00+18.5% |
|
Aug 23
00:42 UTC
|
ROST
Ross Stores
|
◎ Target | Matthew Boss ★★★☆☆ #1461 | Overweight | $262.00→ $272.00+3.8% |
|
Aug 23
00:42 UTC
|
ROST
Ross Stores
|
◎ Target | Mark Altschwager ★★★☆☆ #1370 | Outperform | $250.00→ $270.00+8.0% |
|
Aug 23
00:42 UTC
|
ROST
Ross Stores
|
◎ Target | Paul Lejuez ★★★☆☆ #1391 | Buy | $270.00→ $290.00+7.4% |
|
Aug 23
00:42 UTC
|
ROST
Ross Stores
|
◎ Target | Adrienne Yih ★★★☆☆ #1980 | Overweight | $260.00→ $298.00+14.6% |
|
Aug 23
00:42 UTC
|
ROST
Ross Stores
|
◎ Target | Ike Boruchow ★★★☆☆ #2063 | Equal Weight | $245.00→ $248.00+1.2% |
|
Aug 23
00:42 UTC
|
ROST
Ross Stores
|
◎ Target | Jay Sole ★★★☆☆ #2119 | Neutral | $232.00→ $239.00+3.0% |
|
Aug 23
00:42 UTC
|
ROST
Ross Stores
|
◎ Target | Corey Tarlowe ★★★★☆ #603 | Buy | $265.00→ $285.00+7.5% |
|
Aug 23
00:42 UTC
|
ROST
Ross Stores
|
◎ Target | Alex Straton not yet tracked | Equal Weight | $231.00→ $234.00+1.3% |
|
Aug 23
00:42 UTC
|
ROST
Ross Stores
|
◎ Target | Aneesha Sherman ★★☆☆☆ #2688 | Market Perform | $230.00→ $240.00+4.3% |
|
Aug 23
00:42 UTC
|
ROST
Ross Stores
|
◎ Target | Joseph Civello ★★★☆☆ #2033 | Buy | $290.00→ $310.00+6.9% |
|
Aug 23
00:42 UTC
|
ROK
Rockwell Automation
|
◎ Target | Chris Dankert ★★★☆☆ #2092 | Neutral | $500.00→ $490.00-2.0% |
|
Aug 23
00:42 UTC
|
RITM
Rithm Capital
|
◎ Target | Douglas Harter ★★★★☆ #385 | Buy | $14.50→ $14.00-3.4% |
|
Aug 23
00:42 UTC
|
RDDT
Reddit
|
◎ Target | Brian Nowak ★★☆☆☆ #2731 | Overweight | $240.00→ $210.00-12.5% |
|
Aug 23
00:42 UTC
|
RBRK
Rubrik
|
◎ Target | Eric Heath ★★★★☆ #336 | Overweight | $100.00→ $112.00+12.0% |
|
Aug 23
00:42 UTC
|
RARE
Ultragenyx Pharmaceutical
|
◎ Target | Jeffrey Hung not yet tracked | Overweight | $67.00→ $74.00+10.4% |
|
Aug 23
00:42 UTC
|
PPL
PPL
|
◎ Target | David Arcaro ★★★☆☆ #2079 | Overweight | $43.00→ $42.00-2.3% |
|
Aug 23
00:42 UTC
|
PNW
Pinnacle West Capital
|
◎ Target | David Arcaro ★★★☆☆ #2079 | Equal Weight | $97.00→ $94.00-3.1% |
|
Aug 23
00:42 UTC
|
PMT
PennyMac Mortgage Investment Trust
|
◎ Target | Marissa Lobo not yet tracked | Neutral | $11.25→ $10.00-11.1% |
|
Aug 23
00:42 UTC
|
PGNY
Progyny
|
◎ Target | Lisa Gill ★★★★☆ #658 | Neutral | $27.00→ $30.00+11.1% |
|
Aug 23
00:42 UTC
|
PEG
Public Service Enterprise Group
|
◎ Target | David Arcaro ★★★☆☆ #2079 | Overweight | $93.00→ $91.00-2.2% |
|
Aug 23
00:42 UTC
|
PCG
Pacific Gas & Electric
|
◎ Target | David Arcaro ★★★☆☆ #2079 | Equal Weight | $23.00→ $22.00-4.3% |
|
Aug 23
00:42 UTC
|
P
Everpure
|
◎ Target | Matt Bryson ★★★☆☆ #1201 | Outperform | $105.00→ $127.00+21.0% |
|
Aug 23
00:42 UTC
|
OSIS
OSI Systems
|
◎ Target | Christopher Glynn ★★★★☆ #863 | Outperform | $320.00→ $300.00-6.2% |
|
Aug 23
00:42 UTC
|
OSB
OSB Group
|
◎ Target | firm only | Hold | GBX 660→ GBX 615-6.8% |
|
Aug 23
00:42 UTC
|
OKTA
Okta
|
◎ Target | Brian Essex ★★☆☆☆ #2274 | Overweight | $120.00→ $165.00+37.5% |
|
Aug 23
00:42 UTC
|
OGS
ONE Gas
|
◎ Target | Stephen Byrd ★☆☆☆☆ #3175 | Equal Weight | $86.00→ $82.00-4.7% |
|
Aug 23
00:42 UTC
|
OGE
OGE Energy
|
◎ Target | David Arcaro ★★★☆☆ #2079 | Equal Weight | $51.00→ $49.00-3.9% |
|
Aug 23
00:42 UTC
|
NWSA
News
|
◎ Target | David Karnovsky ★★★★☆ #927 | Overweight | $36.00→ $38.00+5.6% |
|
Aug 23
00:42 UTC
|
NTSK
Netskope
|
◎ Target | Eric Heath ★★★★☆ #336 | Overweight | $16.00→ $17.50+9.4% |
|
Aug 23
00:42 UTC
|
NRG
NRG Energy
|
◎ Target | Stephen Byrd ★☆☆☆☆ #3175 | Equal Weight | $165.00→ $162.00-1.8% |
|
Aug 23
00:42 UTC
|
NDSN
Nordson
|
◎ Target | Michael Halloran ★★★★☆ #501 | Neutral | $328.00→ $351.00+7.0% |
|
Aug 23
00:42 UTC
|
NDSN
Nordson
|
◎ Target | Christopher Glynn ★★★★☆ #863 | Outperform | $335.00→ $370.00+10.4% |
|
Aug 23
00:42 UTC
|
NA
National Bank of Canada
|
◎ Target | firm only | C$188.00→ C$220.00+17.0% | |
|
Aug 23
00:42 UTC
|
MRVL
Marvell Technology
|
◎ Target | Atif Malik ★★★☆☆ #1475 | Buy | $225.00→ $275.00+22.2% |
|
Aug 23
00:42 UTC
|
MRNA
Moderna
|
◎ Target | Jessica Fye ★★★☆☆ #1851 | Underweight | $40.00→ $77.00+92.5% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.